Fig. 3From: EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging qualityDistribution of Am as described in literature for the clinically applied PET-tracers [11C]PIB, [11C]raclopride, [11C]choline and [11C]verapamil produced at different PET-centresBack to article page